Media reports suggest that the UK has also had talks with GSK and Sanofi about a supply agreement. (File)
London:
Britain has denied the possibility of joining a 2.4 billion euro ($ 2.7 billion) EU plan to guarantee advance purchases of promising COVID-19 vaccines, saying the EU would not allow him any role in decision making.
“The British government has decided on this occasion not to join this internal EU initiative, but given our common interest in ensuring that vaccines are available to all, we are committed to strengthening our collaboration with the EU outside of the framework, “said British Ambassador EU, said Tim Barrow.
Before making his decision, he had assessed whether the advantages of the European bloc’s negotiating power to conclude agreements with international pharmaceutical companies would outweigh the fact that Great Britain would have little control over the strategy.
With the highest number of coronavirus deaths in Europe, Britain is struggling to reopen its economy and will end a transition period with the European Union later this year.
Earlier this year, Britain did not join an EU supply program for fans due to what officials described as a communication problem.
Barrow said joining the EU program would have required Britain to end its own talks with manufacturers, and no votes would have been given on “with which manufacturers to negotiate or the price, volume and delivery schedule negotiated. “
With more than 550,000 deaths worldwide and a virus still on the move, major governments are in a race to secure vaccine supplies in a desperate attempt to get their economies back on track.
Britain has already signed an agreement to secure 100 million doses of an experimental vaccine that was developed by the University of Oxford and licensed by the British drug maker AstraZeneca.
Media reports suggest that he also had talks with GSK and Sanofi about a supply agreement.
Talks with the EU have determined whether the two sides could work together to deal with international emergencies after Brexit. The EU said before the announcement that Britain’s decision to reject the program would not affect the talks it had with drug manufacturers.
As part of the EU plan, the bloc wants to buy or commit to buying promising vaccines before they are ready, taking the risk of potential clinical failure. In exchange, he would have priority access to the pictures.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)
